Clinical Trial 35956

share

Long Beach, CA 90806


Study Summary:

This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild AD.


Qualified Participants Must:

• Be diagnosed with Alzheimer's disease
• Be between 50 and 85 years of age (Adult, Senior)


Qualified Participants May Receive:

Study-related medical care and investigational drug at no cost and may be compensated for time and travel.


Study is Available At:

CNS
2600 Redondo Ave
5th floor
Long Beach, CA 90806
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 100 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.